Neoplasia: An International Journal for Oncology Research
Elsevier
About the journal
Neoplasia: An International Journal for Oncology Research is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,790 USD. Declared review time at DOAJ: 13 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 1522-8002 · 1476-5586
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,790 USD
- Articles in DOAJ
- 2784
- Declared review time
- 13 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/neoplasia
Index listings
- DOAJ · 2008-04-04
- MEDLINE · 1999-01-01
- PUBMED · 2023-10-27
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 3,790 USD
- Declared review time (DOAJ)
- 13 weeks
- Actual review time (measured)
- 62 days received→accepted — computed from PubMed (n=91)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
2784
Most recent article
last month
Average review time (journal-declared via DOAJ)
13weeks
Works in OpenAlex
2892
Last recorded publication year
2026
h-index
159
i10-index
2325
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2008-04-04
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 92%
- ORCID iDs in current deposits
- 76%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 100886622
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
Show all subjects (50)
- Angiogenesis and VEGF in Cancer
- Angiogenesis and VEGF in Cancer
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Cell Adhesion Molecules Research
- Cell Adhesion Molecules Research
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer-related gene regulation
- Cancer-related gene regulation
- Immune cells in cancer
- Immune cells in cancer
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- RNA modifications and cancer
- RNA modifications and cancer
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
- Cancer Research and Treatments
- Cancer Research and Treatments
- Cancer Immunotherapy and Biomarkers
- DNA Repair Mechanisms
- Cancer Immunotherapy and Biomarkers
- DNA Repair Mechanisms
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- Neuroblastoma Research and Treatments
- Neuroblastoma Research and Treatments
- Cytokine Signaling Pathways and Interactions
- Cytokine Signaling Pathways and Interactions
Keywords (DOAJ)
- molecular mechanisms of cancer
- cancer genomics and tumor evolution
- functional and systems oncology
- biomarker discovery and validation
- translational and experimental therapeutics
- precision oncolog
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ